Skip to main content
SpringerLink
Log in

The EMA’s Pharmacovigilance Working Party (PhVWP) is recommending that labels for proton pump inhibitors (PPIs) be updated

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA Pharmacovigilance Working Party (PhVWP).Proton-pump inhibitors - Risk of bone fracture. PhVWP Monthly Report: 2 [+ Annex 2], No. 1203, 22 Mar 2012. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EMA’s Pharmacovigilance Working Party (PhVWP) is recommending that labels for proton pump inhibitors (PPIs) be updated. React. Wkly. 1397, 3 (2012). https://doi.org/10.2165/00128415-201213970-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213970-00006

Keywords

Search

Navigation